Depomed, Inc. (DEPO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
23.21-0.05 (-0.21%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close23.26
Bid0.00 x
Ask0.00 x
Day's Range22.95 - 23.56
52wk Range12.25 - 27.02
1y Target EstN/A
Market Cap1.43B
P/E Ratio (ttm)-19.07
Avg Vol (3m)1,407,661
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals7 days ago

    East Bay drug maker wards off hedge fund challenge — with a price

    For the second time in a year, Depomed Inc. stared down a corporate challenge, striking an 11th-hour deal with its second-largest shareholder to sidestep a pivotal vote to throw out and replace its board. The Newark-based pain drug company (DEPO) will expand its board by three directors — all with ties to New York hedge fund Starboard Value LP — and reimburse Starboard up to $1 million for its costs in bringing the challenge to Depomed's board. Starboard, led by managing member Jeffrey C. Smith, had said Depomed's stock was undervalued and had raised "significant concerns" about Depomed's management, spending decisions and moves to undercut an attempted $2 billion hostile takeover by Horizon Pharma plc (HZNP).

  • Why Visa, Johnson and Johnson, Pfizer, and Two Other Stocks Are in Spotlight Today
    Insider Monkey8 days ago

    Why Visa, Johnson and Johnson, Pfizer, and Two Other Stocks Are in Spotlight Today

    Although the earnings reports of various tech companies have mostly commanded the spotlight this Tuesday, the shares of five companies, Visa Inc (NYSE:V), Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Depomed Inc (NASDAQ:DEPO), and Corrections Corp Of America (NYSE:CXW) are also trending for various reasons. Let’s take a closer look at why each traders are closely […]

  • 24/7 Wall St.8 days ago

    Is Settling With an Activist Investor Supposed to Be Bad for Shareholders?

    Depomed has settled with Starboard Value in a move that will bring this activist investor fight to a close. At least for now.